Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator

Cancer Research

Volumn 61, Issue 10, 2001, Pages 3902-3907

  McDougal, A ^a   Wormke, M ^a   Calvin, J ^a   Safe, S ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,8 TRICHLORO 6 METHYLDIBENZOFURAN; AROMATIC HYDROCARBON RECEPTOR; AROMATIC HYDROCARBON RECEPTOR MODULATING AGENT; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HORMONE RECEPTOR AFFECTING AGENT; PEROXIDASE; PROGESTERONE RECEPTOR; PROTEASOME; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE GROWTH; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; UTERUS;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BENZOFURANS; BONE DEVELOPMENT; CYSTEINE ENDOPEPTIDASES; DRUG SYNERGISM; ESTROGEN RECEPTOR MODULATORS; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ARYL HYDROCARBON; TAMOXIFEN; UTERUS;

EID: 0035872466     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Recent trends in U.S. breast cancer incidence, survival, and mortality rates
2. Basic guide to the mechanisms of antiestrogen action
3. Therapeutic potential of selective estrogen receptor modulators
4. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
5. Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14
6. Effect of retinoid X receptor-selective ligand LGD1069 on mammary carcinoma after tamoxifen failure
7. A new ligand for the peroxisome proliferator-activated receptor-γ (PPAR-γ), GW7845, inhibits rat mammary carcinogenesis
8. Development of selective aryl hydrocarbon receptor modulators (SARMs) for treatment of breast cancer
9. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol: Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase
10. Results of a 2-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats
11. Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin
12. Correlation of in vitro and in vivo growth suppression of MCF-7 human breast cancer by 2,3,7,8-tetrachlorodibenzo-p-dioxin
13. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds
14. Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells
15. Crosstalk between estrogen receptor α and the aryl hydrocarbon receptor in breast cancer cells involves unidirectional activation of proteasomes
16. Enhancement of 2- and 16-α-estradiol hydroxylation in MCF-7 human breast cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin
17. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells
18. Identification of a motif within the 5′ regulatory region of pS2 which is responsible for AP-1 binding and TCDD-mediated suppression
19. Transcriptional activation of c-fos proto-oncogene by 17β-estradiol: Mechanism of aryl hydrocarbon receptor-mediated inhibition
20. Cancer incidence in a population accidentally exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin
21. The anti-estrogenic effect of cigarette smoking in women
22. Aryl hydrocarbon receptor-mediated anti-estrogenic and antitumorigenic activity of diindolylmethane
23. Inhibition of carcinogen-induced rat mammary tumor growth and other estrogen-dependent responses by symmetrical dihalo-substituted analogs of diindolylmethane
24. Inhibition of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor growth by arylhydrocarbon receptor agonists
25. Alkyl polychlorinated dibenzofurans and related compounds as anti-estrogens in the female rat uterus: Structure-activity studies
26. Simple designs and model-free tests for synergy
27. 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: Inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities
28. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats
29. Cyclic estradiol treatment normalizes body weight and test meal size in ovariectomized rats
30. Proteasome-dependent degradation of the human estrogen receptor
31. Implication of proteasome in estrogen receptor degradation
32. Proteasome-mediated proteolysis of estrogen receptor: A novel component in autologous down-regulation
33. Regulation of estrogen receptor expression in breast cancer
34. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines
35. Effects of tamoxifen on human breast cancer cells in vitro
36. Modulation of endometrial steroid receptors and growth regulatory genes by tamoxifen
37. Steroid receptor expression in endometria from women treated with tamoxifen
38. Alterations in steroid hormone receptors in the tamoxifen-treated endometrium
39. Effects of tamoxifen on endometrial estrogen and progesterone receptor concentrations in women with fibrocystic disease of the breast
40. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen